OPT · ASX

Opthea Limited (ASX:OPT)

AU$0.62

 -0.035 (-5.303%)
ASX:Live
21/11/2024 04:10:42 PM
HALO Small HALO Ords HALO Consensus Value HALO Capital Efficiency GROWTH AUS +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

OPT Overview

OPT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Very Strong

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Strong

About OPT

Website

Opthea Limited

Telephone

61.3.9826.0399

Address

Level 4 Suite 0403 650 Chapel Street South Yarra, Victoria (VIC) 3141

Description

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984, and is headquartered in South Yarra, Australia.

OPT Price Chart

Key Stats

Market Cap

AU$794.06M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.34 - 0.95

Trade Value (12mth)

AU$386,109.00

1 week

0.76%

1 month

-27.47%

YTD

26.83%

1 year

93.67%

All time high

3.60

Key Fundamentals

EPS 3 yr Growth

219.70%

EBITDA Margin

%

Operating Cashflow

-$246m

Free Cash Flow Return

-275.90%

ROIC

-377.40%

Interest Coverage

-6.30

Quick Ratio

2.90

Other Data

Shares on Issue (Fully Dilluted)

679m

HALO Sector

Healthcare

Next Company Report Date

28-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

1.14

OPT Announcements

Latest Announcements

Date Announcements

15 November 24

Chair's Address to Shareholders

×

Chair's Address to Shareholders

15 November 24

Director Appointment/Resignation

×

Director Appointment/Resignation

15 November 24

Results of Meeting

×

Results of Meeting

15 November 24

Opthea Received A$15.9 Million R&D Tax Incentive

×

Opthea Received A$15.9 Million R&D Tax Incentive

15 November 24

Initial Director's Interest Notice

×

Initial Director's Interest Notice

12 November 24

Opthea's Wet AMD Program Featured at Ophthalmology Events

×

Opthea's Wet AMD Program Featured at Ophthalmology Events

04 November 24

Opthea to Participate in November Investor Conferences

×

Opthea to Participate in November Investor Conferences

04 November 24

Update Opthea Participates in November Investor Conferences

×

Update Opthea Participates in November Investor Conferences

31 October 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

28 October 24

Opthea Corporate Presentation - Oct 2024

×

Opthea Corporate Presentation - Oct 2024

16 October 24

Opthea Files Notice of Annual General Meeting

×

Opthea Files Notice of Annual General Meeting

16 October 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

10 October 24

Opthea Wet AMD Program to be Presented at Innovate Retina

×

Opthea Wet AMD Program to be Presented at Innovate Retina

08 October 24

Opthea Appoints Chief Medical and Chief Financial Officer

×

Opthea Appoints Chief Medical and Chief Financial Officer

04 October 24

Becoming a substantial holder

×

Becoming a substantial holder

01 October 24

Opthea to participate in UBS Virtual Ophthalmology Day 2024

×

Opthea to participate in UBS Virtual Ophthalmology Day 2024

26 September 24

Opthea EURetina Symposium 2024

×

Opthea EURetina Symposium 2024

23 September 24

Opthea Joins the S&P/ASX 300 Index

×

Opthea Joins the S&P/ASX 300 Index

19 September 24

Opthea Announces Completion of Drug Substance Campaign

×

Opthea Announces Completion of Drug Substance Campaign

11 September 24

Opthea Presents at the 24th EURETINA Congress

×

Opthea Presents at the 24th EURETINA Congress

09 September 24

Opthea Corporate Presentation - September 2024

×

Opthea Corporate Presentation - September 2024

06 September 24

S&P DJI Announces September 2024 Quarterly Rebalance

×

S&P DJI Announces September 2024 Quarterly Rebalance

05 September 24

Opthea Announces Executive Leadership Changes & Senior Hires

×

Opthea Announces Executive Leadership Changes & Senior Hires

04 September 24

Opthea presents at H.C.Wainwright 26th Investment Conference

×

Opthea presents at H.C.Wainwright 26th Investment Conference

30 August 24

Opthea Preliminary Final and Annual Report

×

Opthea Preliminary Final and Annual Report

OPT Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.32 -0.42 -0.53 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.32 -0.42 -0.53 Lock Lock Lock
     Growth % Lock Lock Lock Lock -91.9 -31.5 -26.7 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.29 -0.37 -0.25 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.24 -0.35 -0.39 Lock Lock Lock
     Growth % Lock Lock Lock Lock -199.6 -27.2 32.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock -25.4 -73.7 -110.0 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.17 -0.02 -0.10 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.17 -0.02 -0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -61.4 -109.5 -536.4 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 405 510 638 Lock Lock Lock
Basic m Lock Lock Lock Lock 405 510 638 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 35.9 28.9 18.0 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 133 223 293 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.0 0.0 17.4 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 0 0 83 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -133 -223 -293 Lock Lock Lock
     Growth % Lock Lock Lock Lock -151.1 -67.7 -31.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -106,489.5 -138,554.5 -153,912.8 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -133 -223 -293 Lock Lock Lock
     Growth % Lock Lock Lock Lock -150.6 -67.7 -31.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -106,576.0 -138,647.9 -153,995.4 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -137 -221 -350 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -9 -9 -14 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -128 -212 -336 Lock Lock Lock
     Growth % Lock Lock Lock Lock -110.6 -65.5 -58.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -102,353.7 -131,469.7 -176,665.7 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -98 -179 -246 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 249 372 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -98 -179 -246 Lock Lock Lock
     Growth % Lock Lock Lock Lock -61.1 -82.3 -37.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -786.8 -1,112.8 -1,291.8 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 65 134 258 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 87 148 283 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 300 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -65 -134 42 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 18 157 396 Lock Lock Lock
Equity $m Lock Lock Lock Lock 70 -9 -114 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 70 -9 187 Lock Lock Lock
     Growth % Lock Lock Lock Lock -61.3 -112.4 2,254.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -146.6 -143.0 -118.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -183.4 2,409.6 296.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -106.6 -729.6 -328.5 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -102.4 -693.5 -377.4 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -78.7 -586.9 -275.9 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock N/A -11.2 -6.3 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.5 0.6 -0.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -93.0 1,520.7 -37.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 5.0 5.2 2.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 5.0 5.2 2.9 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 74.5 90.7 91.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -561.7 -636.8 -256.2 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 13,260.1 16,632.4 29,955.2 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -109,300.2 -136,936.5 -184,215.7 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -156.5 -148.9 -124.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -146.6 -143.0 -118.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 -16.9 -2.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -183.4 2,409.6 296.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -183.4 2,409.6 296.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 24,682.5 21,962.4 26,442.3 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 24,682.5 21,962.4 26,442.3 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 0.0 0.0 96,052.6 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 24,682.5 21,962.4 -69,610.3 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

1.14%

Value ($M)

10

Prior Change

N/A

7 Day Change

N/A

1 Month Change

0.20%

3 Month Change

1.00%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

OPT Shortsell

Frequently Asked Questions

The current share price of Opthea Limited (OPT:ASX) is AU$0.62.
The 52-week high share price for Opthea Limited (OPT:ASX) is AU$0.95.
The 52-week low share price for Opthea Limited (OPT:ASX)? is AU$0.34.
Opthea Limited (OPT:ASX) does not pay a dividend.
The last dividend payment of Opthea Limited (OPT:ASX) is AU$1.15.
Opthea Limited (OPT:ASX) has a franking level of 0.0%.
Opthea Limited (OPT:ASX) is classified in the Healthcare.
The current P/E ratio for Opthea Limited (OPT:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.